Betaloc belongs to the β-protein kinase inhibitor, a first-line effective blood pressure-lowering drug, but the blood pressure-lowering effect is not very obvious. In clinical practice, it has a certain effect on primary hypertension or mild hypertension. If the patient’s blood pressure is currently high, this drug can be used as an auxiliary drug in the medication plan, but it cannot be used alone to lower the patient’s blood pressure to a safe range. In addition to lowering blood pressure, it also has the effects of slowing down the patient’s heartbeat, preventing the remodeling of the left ventricle, and improving the patient’s myocardial ischemia, which is the second-level prevention medication for heart failure and angina. In addition to blood pressure-lowering, it also has many other secondary prevention effects. Although the blood pressure-lowering effect is generally good, Betaloc is an excellent drug. If the blood pressure is high, Betaloc can be used in combination to lower blood pressure, but it cannot be used independently to control blood pressure effectively.

For hypertension patients with relatively low blood pressure and slow heartbeat, Betaloc can be used as the first choice, that is, it can be used independently.

In clinical medicine, the blood pressure of the vast majority of hypertension patients is difficult to be normalized with a single blood pressure-lowering drug, especially since the blood pressure-lowering effect of Betaloc itself is relatively weak, therefore, it is often necessary to use two or more blood pressure-lowering drugs in combination, which has a blood pressure-lowering effect of 1+1>2.

Hypertension + rapid heartbeat, central nervous system excitation is one of the causes of hypertension, and central nervous system excitation is mainly manifested as an increase in heart rate, in other words, in addition to lowering blood pressure, the heart rate also needs to be lowered, only in this way can blood pressure be controlled more effectively.

Since Betaloc is not only a blood pressure-lowering drug but also the foundation of heart failure treatment, it can also reduce the mortality rate of myocardial infarction and the mortality rate of arrhythmias, therefore, in the case of hypertension + myocardial infarction, hypertension + heart failure, hypertension + arrhythmia, hypertension + angina, Betaloc is used.

In summary, Betaloc is the most common medication in the clinical medicine of cardiovascular diseases, and it is not only a blood pressure-lowering drug!